Bioengineer Humans to Tackle Climate Change, Say Philosophers
By Leo Hickman,
Guardian
| 03. 14. 2012
Earlier this week, The Atlantic ran an eye-catching disturbing interview with a professor of philosophy and bioethics at New York University called S. Matthew Liao. He was invited to discuss a forthcoming paper he has co-authored which will soon be published in the journal Ethics, Policy & Environment.
But within just a few hours of the interview going live a torrent of outrage and abuse was being directed towards him online. As I tweeted at the time, the interview was indeed "unsettling". Liao explained how his paper – entitled, "Human Engineering and Climate Change" – explored the so-far-ignored subject of how "biomedical modifications of humans" could be used to "mitigate and/or adapt to climate change". The modifications discussed included: giving people drugs to make them have an adverse reaction to eating meat; making humans smaller via gene imprinting and "preimplantation genetic diagnosis"; lowering birth-rates through "cognitive enhancement"; genetically engineering eyesight to work better in the dark to help reduce the need for lighting; and the "pharmacological enhancement of altruism and empathy" to engender a...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...